SEC Form 4 · accession 0001467874-16-000001
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carter Julian Ward
Officer — CFO, Secretary, Treasurer
Period of report
Apr 28, 2016
Accepted (ET)
May 3, 2016 · 11:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 28, 2016 | C | 666,667 | $0.0625 | A | 1,752,285 | D | |
| Common Stock | holding | — | — | — | 1,355,014 | I | by IRA of Carter Ward |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.0625 | Apr 28, 2016 | C | 666,667 | D | Jun 3, 2009 | Jun 3, 2016 | Common Stock | 666,667 | 0 | D |